Success Metrics

Clinical Success Rate
50.0%

Based on 2 completed trials

Completion Rate
50%(2/4)
Active Trials
0(0%)
Results Posted
200%(4 trials)
Terminated
2(50%)

Phase Distribution

Ph phase_3
3
75%
Ph phase_2
1
25%

Phase Distribution

0

Early Stage

1

Mid Stage

3

Late Stage

Phase Distribution4 total trials
Phase 2Efficacy & side effects
1(25.0%)
Phase 3Large-scale testing
3(75.0%)

Highest Phase Reached

Phase 3

Trial Status & Enrollment

Completion Rate

50.0%

2 of 4 finished

Non-Completion Rate

50.0%

2 ended early

Currently Active

0

trials recruiting

Total Trials

4

all time

Status Distribution
Completed(2)
Terminated(2)

Detailed Status

Terminated2
Completed2

Development Timeline

Analytics

Development Status

Total Trials
4
Active
0
Success Rate
50.0%
Most Advanced
Phase 3

Trials by Phase

Phase 21 (25.0%)
Phase 33 (75.0%)

Trials by Status

terminated250%
completed250%

Recent Activity

0 active trials
Showing 4 of 4
completedphase_3

Evaluation of the Efficacy and Safety of Two Dosing Regimens of Olokizumab (OKZ), Compared to Placebo and Adalimumab, in Subjects With Rheumatoid Arthritis (RA) Who Are Taking Methotrexate But Have Active Disease

NCT02760407
terminatedphase_3

A Study in Participants With Rheumatoid Arthritis

NCT01202773
terminatedphase_3

A Rheumatoid Arthritis Study in Participants on a Background Treatment of Methotrexate

NCT01198002
completedphase_2

A Safety and Efficacy Study of Tralokinumab in Adults With Asthma

NCT01402986

Clinical Trials (4)

Showing 4 of 4 trials
NCT02760407Phase 3

Evaluation of the Efficacy and Safety of Two Dosing Regimens of Olokizumab (OKZ), Compared to Placebo and Adalimumab, in Subjects With Rheumatoid Arthritis (RA) Who Are Taking Methotrexate But Have Active Disease

Completed
NCT01202773Phase 3

A Study in Participants With Rheumatoid Arthritis

Terminated
NCT01198002Phase 3

A Rheumatoid Arthritis Study in Participants on a Background Treatment of Methotrexate

Terminated
NCT01402986Phase 2

A Safety and Efficacy Study of Tralokinumab in Adults With Asthma

Completed

All 4 trials loaded

Drug Details

Intervention Type
OTHER
Total Trials
4